These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36683720)

  • 1. Retraction note to: Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.
    Sun QH; Wang HY; Sun SD; Zhang X; Zhang H
    World J Gastroenterol; 2023 Jan; 29(1):221-222. PubMed ID: 36683720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.
    Sun QH; Wang HY; Sun SD; Zhang X; Zhang H
    World J Gastroenterol; 2019 May; 25(17):2110-2121. PubMed ID: 31114137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction.
    Saudi J Anaesth; 2020; 14(3):422. PubMed ID: 32934651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction note to four articles published in
    Cui Q
    World J Orthop; 2018 Mar; 9(3):58-59. PubMed ID: 29564215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double blind, controlled, multi center study of Ilaparazole in the treatment of reflux esophagitis-Phase III clinical trial.
    Xue Y; Qin X; Zhou L; Lin S; Wang L; Hu H; Xia J
    Contemp Clin Trials; 2018 May; 68():67-71. PubMed ID: 29540336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction Note.
    Kowsar Publishing Company
    Iran Red Crescent Med J; 2016 Mar; 18(3):e43586. PubMed ID: 27830082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA; Benjamin SB; Vakil NB; Goldstein JL; Lamet M; Whipple J; Damico D; Hamelin B
    Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis.
    Xue Y; Qin X; Zhou L; Lin S; Wang L; Hu H; Xia J
    Clin Drug Investig; 2016 Dec; 36(12):985-992. PubMed ID: 27605258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis.
    Zheng RN
    World J Gastroenterol; 2009 Feb; 15(8):990-5. PubMed ID: 19248200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.
    Peterson KA; Thomas KL; Hilden K; Emerson LL; Wills JC; Fang JC
    Dig Dis Sci; 2010 May; 55(5):1313-9. PubMed ID: 19533356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
    Devault KR; Johanson JF; Johnson DA; Liu S; Sostek MB
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):852-9. PubMed ID: 16682260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    BMC Pediatr; 2010 Jun; 10():41. PubMed ID: 20540767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
    Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26121347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26422095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction.
    Saudi J Anaesth; 2022; 16(1):144. PubMed ID: 35261616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction Note: Construction of Gpm6a/ReelinGFPCreERT2 by BAC recombination using a specific gene in hepatic mesothelial or stellate cells.
    Shi HB; Lou JL; Shi HL; Ren F; Chen Y; Duan ZP
    World J Gastroenterol; 2019 Jul; 25(25):3281-3282. PubMed ID: 31333318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study.
    Hong SJ; Park SH; Moon JS; Shin WG; Kim JG; Lee YC; Lee DH; Jang JY; Kim JJ; Lee HL; Lee SW; Hwangbo Y; Xu J; Wang B; Xue Z; Liu F; Yuan Y; Leelakusolvong S; Dy F
    Gut Liver; 2016 Nov; 10(6):910-916. PubMed ID: 27282265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis.
    Lee KN; Lee OY; Chun HJ; Kim JI; Kim SK; Lee SW; Park KS; Lee KL; Choi SC; Jang JY; Kim GH; Sung IK; Park MI; Kwon JG; Kim N; Kim JJ; Lee ST; Kim HS; Kim KB; Lee YC; Choi MG; Lee JS; Jung HY; Lee KJ; Kim JH; Chung H
    World J Gastroenterol; 2022 Nov; 28(44):6294-6309. PubMed ID: 36504556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction note to: Strategy for prevention of hip fractures in patients with Parkinson's disease.
    Cui Q
    World J Orthop; 2017 Oct; 8(10):814. PubMed ID: 29094013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.